

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 4.88809759 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 4.88809759 |
| 3 | protein maturation by protein folding (GO:0022417) | 4.78869946 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.67190788 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.67190788 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.62067318 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 4.62067318 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 4.33797026 |
| 9 | sulfur amino acid catabolic process (GO:0000098) | 4.29195400 |
| 10 | valine metabolic process (GO:0006573) | 4.19359734 |
| 11 | cysteine metabolic process (GO:0006534) | 4.16303102 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.04956768 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 4.04421767 |
| 14 | lysine metabolic process (GO:0006553) | 3.98363647 |
| 15 | lysine catabolic process (GO:0006554) | 3.98363647 |
| 16 | protein carboxylation (GO:0018214) | 3.96078635 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.96078635 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.85403591 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 3.79775992 |
| 20 | glyoxylate metabolic process (GO:0046487) | 3.78468369 |
| 21 | glycine metabolic process (GO:0006544) | 3.73933710 |
| 22 | kynurenine metabolic process (GO:0070189) | 3.73032247 |
| 23 | complement activation, alternative pathway (GO:0006957) | 3.72619074 |
| 24 | urea metabolic process (GO:0019627) | 3.72179797 |
| 25 | urea cycle (GO:0000050) | 3.72179797 |
| 26 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.71467938 |
| 27 | 4-hydroxyproline metabolic process (GO:0019471) | 3.59087408 |
| 28 | GDP-mannose metabolic process (GO:0019673) | 3.58978937 |
| 29 | proline biosynthetic process (GO:0006561) | 3.58878122 |
| 30 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.58666416 |
| 31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.57209392 |
| 32 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.57209392 |
| 33 | regulation of protein activation cascade (GO:2000257) | 3.54808634 |
| 34 | indole-containing compound catabolic process (GO:0042436) | 3.53589081 |
| 35 | indolalkylamine catabolic process (GO:0046218) | 3.53589081 |
| 36 | tryptophan catabolic process (GO:0006569) | 3.53589081 |
| 37 | homocysteine metabolic process (GO:0050667) | 3.53487999 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 3.49539778 |
| 39 | serine family amino acid catabolic process (GO:0009071) | 3.46146307 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 3.44561908 |
| 41 | high-density lipoprotein particle remodeling (GO:0034375) | 3.43937009 |
| 42 | tryptophan metabolic process (GO:0006568) | 3.42725372 |
| 43 | nitrogen cycle metabolic process (GO:0071941) | 3.42261328 |
| 44 | regulation of cholesterol homeostasis (GO:2000188) | 3.40772318 |
| 45 | bile acid biosynthetic process (GO:0006699) | 3.40748701 |
| 46 | pinocytosis (GO:0006907) | 3.40083352 |
| 47 | COPII vesicle coating (GO:0048208) | 3.39973052 |
| 48 | regulation of complement activation (GO:0030449) | 3.39609998 |
| 49 | serine family amino acid biosynthetic process (GO:0009070) | 3.35208719 |
| 50 | serine family amino acid metabolic process (GO:0009069) | 3.32181755 |
| 51 | tricarboxylic acid metabolic process (GO:0072350) | 3.32035530 |
| 52 | regulation of fibrinolysis (GO:0051917) | 3.26868035 |
| 53 | plasma lipoprotein particle clearance (GO:0034381) | 3.26487503 |
| 54 | low-density lipoprotein particle clearance (GO:0034383) | 3.25849197 |
| 55 | protein retention in ER lumen (GO:0006621) | 3.24259206 |
| 56 | 2-oxoglutarate metabolic process (GO:0006103) | 3.21672919 |
| 57 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.20318424 |
| 58 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.16193618 |
| 59 | reverse cholesterol transport (GO:0043691) | 3.16162798 |
| 60 | negative regulation of sterol transport (GO:0032372) | 3.15612304 |
| 61 | negative regulation of cholesterol transport (GO:0032375) | 3.15612304 |
| 62 | positive regulation of nuclease activity (GO:0032075) | 3.15046426 |
| 63 | pentose-phosphate shunt (GO:0006098) | 3.12046871 |
| 64 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.09216273 |
| 65 | protein-lipid complex remodeling (GO:0034368) | 3.08207802 |
| 66 | macromolecular complex remodeling (GO:0034367) | 3.08207802 |
| 67 | plasma lipoprotein particle remodeling (GO:0034369) | 3.08207802 |
| 68 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.08150061 |
| 69 | aromatic amino acid family metabolic process (GO:0009072) | 3.08139053 |
| 70 | bile acid metabolic process (GO:0008206) | 3.07896598 |
| 71 | glucose catabolic process (GO:0006007) | 3.07679961 |
| 72 | triglyceride homeostasis (GO:0070328) | 3.06896836 |
| 73 | acylglycerol homeostasis (GO:0055090) | 3.06896836 |
| 74 | fatty acid beta-oxidation (GO:0006635) | 3.04685221 |
| 75 | intestinal cholesterol absorption (GO:0030299) | 3.04346361 |
| 76 | cellular modified amino acid catabolic process (GO:0042219) | 3.03309957 |
| 77 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.00071221 |
| 78 | regulation of superoxide anion generation (GO:0032928) | 2.99935131 |
| 79 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.98160802 |
| 80 | ethanol oxidation (GO:0006069) | 2.96734481 |
| 81 | proline metabolic process (GO:0006560) | 2.96718539 |
| 82 | tyrosine metabolic process (GO:0006570) | 2.96261684 |
| 83 | phospholipid efflux (GO:0033700) | 2.95957793 |
| 84 | alpha-amino acid catabolic process (GO:1901606) | 2.95650845 |
| 85 | fatty acid oxidation (GO:0019395) | 2.95040201 |
| 86 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.94791629 |
| 87 | folic acid metabolic process (GO:0046655) | 2.93930135 |
| 88 | regulation of nuclease activity (GO:0032069) | 2.87944580 |
| 89 | lipid oxidation (GO:0034440) | 2.87148826 |
| 90 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.85566028 |
| 91 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.84350805 |
| 92 | NADPH regeneration (GO:0006740) | 2.84195853 |
| 93 | cellular amino acid catabolic process (GO:0009063) | 2.83729949 |
| 94 | lipoprotein metabolic process (GO:0042157) | 2.81890967 |
| 95 | bile acid and bile salt transport (GO:0015721) | 2.81522664 |
| 96 | pentose metabolic process (GO:0019321) | 2.80090987 |
| 97 | plasma lipoprotein particle assembly (GO:0034377) | 2.79660616 |
| 98 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.78595716 |
| 99 | phospholipid homeostasis (GO:0055091) | 2.78326787 |
| 100 | oxaloacetate metabolic process (GO:0006107) | 2.78156668 |
| 101 | one-carbon metabolic process (GO:0006730) | 2.77025092 |
| 102 | positive regulation of lipid catabolic process (GO:0050996) | 2.76792739 |
| 103 | barbed-end actin filament capping (GO:0051016) | 2.75407321 |
| 104 | cellular response to unfolded protein (GO:0034620) | 2.74663280 |
| 105 | drug transmembrane transport (GO:0006855) | 2.74146700 |
| 106 | fatty acid catabolic process (GO:0009062) | 2.74133470 |
| 107 | tetrahydrofolate metabolic process (GO:0046653) | 2.73581505 |
| 108 | branched-chain amino acid metabolic process (GO:0009081) | 2.72674731 |
| 109 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.71893833 |
| 110 | regulation of cholesterol esterification (GO:0010872) | 2.71639633 |
| 111 | carnitine metabolic process (GO:0009437) | 2.71088205 |
| 112 | cholesterol homeostasis (GO:0042632) | 2.69878410 |
| 113 | urate metabolic process (GO:0046415) | 2.68702044 |
| 114 | amyloid precursor protein catabolic process (GO:0042987) | 2.64899411 |
| 115 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.63579297 |
| 116 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.62535749 |
| 117 | * retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.62418546 |
| 118 | UV protection (GO:0009650) | 2.60349758 |
| 119 | NADH metabolic process (GO:0006734) | 2.56195758 |
| 120 | ribosomal small subunit biogenesis (GO:0042274) | 2.55297812 |
| 121 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.48503159 |
| 122 | glycosphingolipid catabolic process (GO:0046479) | 2.48412177 |
| 123 | mitotic nuclear envelope reassembly (GO:0007084) | 2.46820958 |
| 124 | nuclear envelope reassembly (GO:0031468) | 2.46820958 |
| 125 | hyaluronan catabolic process (GO:0030214) | 2.45189649 |
| 126 | NIK/NF-kappaB signaling (GO:0038061) | 2.42018269 |
| 127 | formation of translation preinitiation complex (GO:0001731) | 2.40709094 |
| 128 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.39572129 |
| 129 | establishment of viral latency (GO:0019043) | 2.39229151 |
| 130 | glucose 6-phosphate metabolic process (GO:0051156) | 2.39047545 |
| 131 | pyrimidine-containing compound salvage (GO:0008655) | 2.34291327 |
| 132 | pyrimidine nucleoside salvage (GO:0043097) | 2.34291327 |
| 133 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.32993907 |
| 134 | glycolipid catabolic process (GO:0019377) | 2.32895207 |
| 135 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.31778431 |
| 136 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.31656439 |
| 137 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.28840384 |
| 138 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.28840384 |
| 139 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.25329712 |
| 140 | basement membrane organization (GO:0071711) | 2.21626793 |
| 141 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.19986471 |
| 142 | protein localization to endosome (GO:0036010) | 2.18897676 |
| 143 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.18574796 |
| 144 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.16985794 |
| 145 | fibrinolysis (GO:0042730) | 2.16753820 |
| 146 | virion assembly (GO:0019068) | 2.15365213 |
| 147 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.14621467 |
| 148 | negative regulation of cell size (GO:0045792) | 2.14105280 |
| 149 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.13108492 |
| 150 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.13050411 |
| 151 | regulation of metalloenzyme activity (GO:0048552) | 2.11075181 |
| 152 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.10554865 |
| 153 | response to interferon-beta (GO:0035456) | 2.09627972 |
| 154 | glycoside metabolic process (GO:0016137) | 2.09436163 |
| 155 | purine ribonucleotide transport (GO:0015868) | 2.07721675 |
| 156 | T cell apoptotic process (GO:0070231) | 2.07066475 |
| 157 | modulation by symbiont of host cellular process (GO:0044068) | 2.06754835 |
| 158 | negative regulation of ligase activity (GO:0051352) | 2.06498171 |
| 159 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.06498171 |
| 160 | polyketide metabolic process (GO:0030638) | 2.05583527 |
| 161 | doxorubicin metabolic process (GO:0044598) | 2.05583527 |
| 162 | daunorubicin metabolic process (GO:0044597) | 2.05583527 |
| 163 | heme metabolic process (GO:0042168) | 2.05421884 |
| 164 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.05198365 |
| 165 | galactose catabolic process (GO:0019388) | 2.05175485 |
| 166 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.03688687 |
| 167 | regulation of mitochondrial membrane potential (GO:0051881) | 2.03547722 |
| 168 | peptidyl-proline hydroxylation (GO:0019511) | 2.02695413 |
| 169 | monosaccharide biosynthetic process (GO:0046364) | 2.02609040 |
| 170 | nucleotide salvage (GO:0043173) | 2.02338375 |
| 171 | immunoglobulin mediated immune response (GO:0016064) | 2.02071051 |
| 172 | maternal placenta development (GO:0001893) | 2.01878987 |
| 173 | regulation of mitochondrial translation (GO:0070129) | 2.01520206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.17375775 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.31005428 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.14159136 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.07536539 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.21677326 |
| 6 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.78573919 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.76193302 |
| 8 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.63595950 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.62170928 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.26411027 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.26383875 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.21034657 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.20950248 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.16687121 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.12106677 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.08157815 |
| 17 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.96380969 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.87163210 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 1.86649265 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.84539510 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.79352684 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.78417047 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.77976286 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.77405660 |
| 25 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.71794554 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.70053254 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69255360 |
| 28 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.60772670 |
| 29 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.59785956 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52543585 |
| 31 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.52495170 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.51586258 |
| 33 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51543484 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.49799514 |
| 35 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.42549158 |
| 36 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.42282489 |
| 37 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.41838671 |
| 38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.39846229 |
| 39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.36261880 |
| 40 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.35034312 |
| 41 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.33238725 |
| 42 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32483865 |
| 43 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.29104120 |
| 44 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29030465 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28047097 |
| 46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.27785372 |
| 47 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.25903909 |
| 48 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25737881 |
| 49 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.23921175 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.23670811 |
| 51 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.22852049 |
| 52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.22075681 |
| 53 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21283484 |
| 54 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.20788417 |
| 55 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.20631019 |
| 56 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.19785793 |
| 57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18864006 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.17655708 |
| 59 | P68_20966046_ChIP-Seq_HELA_Human | 1.17585228 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17396161 |
| 61 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.16957912 |
| 62 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.16752058 |
| 63 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14292444 |
| 64 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13434578 |
| 65 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12275683 |
| 66 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.12206404 |
| 67 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12134684 |
| 68 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11872057 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11744931 |
| 70 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.10960645 |
| 71 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.09978208 |
| 72 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08505317 |
| 73 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.08504862 |
| 74 | MAF_26560356_Chip-Seq_TH1_Human | 1.07986541 |
| 75 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07955681 |
| 76 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07562895 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07507189 |
| 78 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06699688 |
| 79 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.06674405 |
| 80 | UTX_26944678_Chip-Seq_JUKART_Human | 1.06291479 |
| 81 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06228188 |
| 82 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06228047 |
| 83 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05106441 |
| 84 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.04704278 |
| 85 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.03218948 |
| 86 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.02743117 |
| 87 | MAF_26560356_Chip-Seq_TH2_Human | 1.02331304 |
| 88 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01588927 |
| 89 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.01299397 |
| 90 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.01275737 |
| 91 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01178617 |
| 92 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00534598 |
| 93 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00170067 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99980650 |
| 95 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.99733695 |
| 96 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.99457096 |
| 97 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.98359065 |
| 98 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98267185 |
| 99 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97394507 |
| 100 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.97302278 |
| 101 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96691741 |
| 102 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.95119735 |
| 103 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95029942 |
| 104 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.94235050 |
| 105 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.94195317 |
| 106 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.93884580 |
| 107 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.93881771 |
| 108 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.93470547 |
| 109 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.92921046 |
| 110 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.92718145 |
| 111 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.92594655 |
| 112 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.92570265 |
| 113 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.92541211 |
| 114 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92255036 |
| 115 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91188330 |
| 116 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.91137194 |
| 117 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.90821923 |
| 118 | MYB_26560356_Chip-Seq_TH1_Human | 0.90513535 |
| 119 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.89196619 |
| 120 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88597436 |
| 121 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.88088216 |
| 122 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87709792 |
| 123 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.87661568 |
| 124 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87047653 |
| 125 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.86610164 |
| 126 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.86393814 |
| 127 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.85791710 |
| 128 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85706663 |
| 129 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.85534384 |
| 130 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.85382090 |
| 131 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.84750751 |
| 132 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.84515555 |
| 133 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.83758248 |
| 134 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.83456740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.97652939 |
| 2 | MP0005360_urolithiasis | 4.55604811 |
| 3 | MP0005365_abnormal_bile_salt | 3.91091747 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.48891417 |
| 5 | MP0009840_abnormal_foam_cell | 3.17531628 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.82650695 |
| 7 | MP0003252_abnormal_bile_duct | 2.60993190 |
| 8 | MP0005451_abnormal_body_composition | 2.60807506 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.58118517 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.49567823 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.45001406 |
| 12 | MP0008260_abnormal_autophagy | 2.33082644 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.14984236 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.13920899 |
| 15 | MP0003195_calcinosis | 2.11044386 |
| 16 | MP0005083_abnormal_biliary_tract | 2.06307038 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.04520756 |
| 18 | MP0005332_abnormal_amino_acid | 1.91640226 |
| 19 | MP0000609_abnormal_liver_physiology | 1.87977967 |
| 20 | MP0004858_abnormal_nervous_system | 1.73627379 |
| 21 | MP0005058_abnormal_lysosome_morphology | 1.67445044 |
| 22 | MP0009643_abnormal_urine_homeostasis | 1.66463730 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.54630364 |
| 24 | MP0006054_spinal_hemorrhage | 1.54000613 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.50724729 |
| 26 | MP0004272_abnormal_basement_membrane | 1.49991430 |
| 27 | MP0005670_abnormal_white_adipose | 1.49459127 |
| 28 | MP0008438_abnormal_cutaneous_collagen | 1.49226686 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.49041448 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.47546360 |
| 31 | MP0002877_abnormal_melanocyte_morpholog | 1.44698877 |
| 32 | MP0005220_abnormal_exocrine_pancreas | 1.44488671 |
| 33 | MP0010352_gastrointestinal_tract_polyps | 1.42775643 |
| 34 | MP0006082_CNS_inflammation | 1.42280333 |
| 35 | MP0005257_abnormal_intraocular_pressure | 1.40849567 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 1.40405942 |
| 37 | MP0009785_altered_susceptibility_to | 1.38227899 |
| 38 | MP0005501_abnormal_skin_physiology | 1.35753670 |
| 39 | MP0002796_impaired_skin_barrier | 1.34862553 |
| 40 | MP0003075_altered_response_to | 1.32357240 |
| 41 | MP0003186_abnormal_redox_activity | 1.31850126 |
| 42 | MP0010234_abnormal_vibrissa_follicle | 1.25819142 |
| 43 | MP0000598_abnormal_liver_morphology | 1.25771959 |
| 44 | MP0002132_abnormal_respiratory_system | 1.25480983 |
| 45 | MP0003436_decreased_susceptibility_to | 1.25282527 |
| 46 | MP0004264_abnormal_extraembryonic_tissu | 1.25118975 |
| 47 | MP0003453_abnormal_keratinocyte_physiol | 1.21854587 |
| 48 | MP0001849_ear_inflammation | 1.20839645 |
| 49 | MP0000343_altered_response_to | 1.20025310 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.16208998 |
| 51 | MP0003566_abnormal_cell_adhesion | 1.15897495 |
| 52 | MP0009278_abnormal_bone_marrow | 1.15019233 |
| 53 | MP0004233_abnormal_muscle_weight | 1.14965141 |
| 54 | MP0005165_increased_susceptibility_to | 1.10705135 |
| 55 | MP0001756_abnormal_urination | 1.10530325 |
| 56 | MP0003868_abnormal_feces_composition | 1.10448629 |
| 57 | MP0000604_amyloidosis | 1.09915751 |
| 58 | MP0005666_abnormal_adipose_tissue | 1.08486116 |
| 59 | MP0001764_abnormal_homeostasis | 1.07667188 |
| 60 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05600775 |
| 61 | MP0001944_abnormal_pancreas_morphology | 1.04594389 |
| 62 | MP0008469_abnormal_protein_level | 1.03376747 |
| 63 | MP0000678_abnormal_parathyroid_gland | 1.02980671 |
| 64 | MP0003693_abnormal_embryo_hatching | 1.02810342 |
| 65 | MP0004185_abnormal_adipocyte_glucose | 1.00665097 |
| 66 | MP0003763_abnormal_thymus_physiology | 0.99903543 |
| 67 | MP0005023_abnormal_wound_healing | 0.99454329 |
| 68 | MP0002452_abnormal_antigen_presenting | 0.98869531 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 0.98739742 |
| 70 | MP0003111_abnormal_nucleus_morphology | 0.98382962 |
| 71 | MP0002723_abnormal_immune_serum | 0.96298547 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 0.96158978 |
| 73 | MP0001790_abnormal_immune_system | 0.95691943 |
| 74 | MP0005387_immune_system_phenotype | 0.95691943 |
| 75 | MP0005636_abnormal_mineral_homeostasis | 0.95667612 |
| 76 | MP0002420_abnormal_adaptive_immunity | 0.94491282 |
| 77 | MP0001819_abnormal_immune_cell | 0.94152532 |
| 78 | MP0000681_abnormal_thyroid_gland | 0.93916721 |
| 79 | MP0002166_altered_tumor_susceptibility | 0.93820930 |
| 80 | MP0002693_abnormal_pancreas_physiology | 0.92997366 |
| 81 | MP0000013_abnormal_adipose_tissue | 0.92159270 |
| 82 | MP0004782_abnormal_surfactant_physiolog | 0.91135784 |
| 83 | MP0001730_embryonic_growth_arrest | 0.91058645 |
| 84 | MP0000685_abnormal_immune_system | 0.90110072 |
| 85 | MP0005464_abnormal_platelet_physiology | 0.89309035 |
| 86 | MP0004947_skin_inflammation | 0.88918955 |
| 87 | MP0009763_increased_sensitivity_to | 0.88182020 |
| 88 | MP0003448_altered_tumor_morphology | 0.86231947 |
| 89 | MP0002136_abnormal_kidney_physiology | 0.85059596 |
| 90 | MP0002429_abnormal_blood_cell | 0.84983447 |
| 91 | MP0002998_abnormal_bone_remodeling | 0.84758250 |
| 92 | MP0001216_abnormal_epidermal_layer | 0.84638310 |
| 93 | MP0003303_peritoneal_inflammation | 0.84287464 |
| 94 | MP0002405_respiratory_system_inflammati | 0.84213431 |
| 95 | MP0005375_adipose_tissue_phenotype | 0.83931616 |
| 96 | MP0001881_abnormal_mammary_gland | 0.83746687 |
| 97 | MP0003724_increased_susceptibility_to | 0.83234542 |
| 98 | MP0001845_abnormal_inflammatory_respons | 0.83196808 |
| 99 | MP0003329_amyloid_beta_deposits | 0.83165265 |
| 100 | MP0005076_abnormal_cell_differentiation | 0.82595008 |
| 101 | MP0004130_abnormal_muscle_cell | 0.82449189 |
| 102 | MP0001542_abnormal_bone_strength | 0.81973225 |
| 103 | MP0002722_abnormal_immune_system | 0.81641735 |
| 104 | MP0005671_abnormal_response_to | 0.80908851 |
| 105 | MP0000465_gastrointestinal_hemorrhage | 0.80875438 |
| 106 | MP0005275_abnormal_skin_tensile | 0.80732914 |
| 107 | MP0002060_abnormal_skin_morphology | 0.80408571 |
| 108 | MP0003172_abnormal_lysosome_physiology | 0.79857737 |
| 109 | MP0004510_myositis | 0.79540949 |
| 110 | MP0000358_abnormal_cell_content/ | 0.79465003 |
| 111 | MP0009642_abnormal_blood_homeostasis | 0.78979714 |
| 112 | MP0008932_abnormal_embryonic_tissue | 0.77592556 |
| 113 | MP0000716_abnormal_immune_system | 0.76778627 |
| 114 | MP0010155_abnormal_intestine_physiology | 0.76416315 |
| 115 | MP0001800_abnormal_humoral_immune | 0.76280349 |
| 116 | MP0008007_abnormal_cellular_replicative | 0.76018094 |
| 117 | MP0010368_abnormal_lymphatic_system | 0.75654738 |
| 118 | MP0000858_altered_metastatic_potential | 0.74633891 |
| 119 | MP0001533_abnormal_skeleton_physiology | 0.74436914 |
| 120 | MP0001835_abnormal_antigen_presentation | 0.73100652 |
| 121 | MP0002970_abnormal_white_adipose | 0.72257248 |
| 122 | MP0005334_abnormal_fat_pad | 0.71386468 |
| 123 | MP0002971_abnormal_brown_adipose | 0.70781396 |
| 124 | MP0002396_abnormal_hematopoietic_system | 0.70637414 |
| 125 | MP0005408_hypopigmentation | 0.70286101 |
| 126 | MP0006036_abnormal_mitochondrial_physio | 0.69795705 |
| 127 | MP0001661_extended_life_span | 0.69568768 |
| 128 | MP0002254_reproductive_system_inflammat | 0.68565587 |
| 129 | MP0000003_abnormal_adipose_tissue | 0.68297452 |
| 130 | MP0001853_heart_inflammation | 0.67910119 |
| 131 | MP0009672_abnormal_birth_weight | 0.65272205 |
| 132 | MP0001243_abnormal_dermal_layer | 0.65266366 |
| 133 | MP0005025_abnormal_response_to | 0.63631399 |
| 134 | MP0002419_abnormal_innate_immunity | 0.63266309 |
| 135 | MP0009764_decreased_sensitivity_to | 0.62625138 |
| 136 | MP0009333_abnormal_splenocyte_physiolog | 0.61698824 |
| 137 | MP0001873_stomach_inflammation | 0.61407379 |
| 138 | MP0002135_abnormal_kidney_morphology | 0.61158674 |
| 139 | MP0009384_cardiac_valve_regurgitation | 0.60775865 |
| 140 | MP0010307_abnormal_tumor_latency | 0.60441721 |
| 141 | MP0004957_abnormal_blastocyst_morpholog | 0.60432224 |
| 142 | MP0002909_abnormal_adrenal_gland | 0.60284485 |
| 143 | MP0003283_abnormal_digestive_organ | 0.59750170 |
| 144 | MP0004043_abnormal_pH_regulation | 0.57035214 |
| 145 | MP0009115_abnormal_fat_cell | 0.56553299 |
| 146 | MP0000477_abnormal_intestine_morphology | 0.56476057 |
| 147 | MP0000490_abnormal_crypts_of | 0.55891651 |
| 148 | MP0001545_abnormal_hematopoietic_system | 0.55848977 |
| 149 | MP0005397_hematopoietic_system_phenotyp | 0.55848977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.88984843 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.60822672 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.58659545 |
| 4 | Xanthomatosis (HP:0000991) | 4.45135034 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.36961588 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 4.29290003 |
| 7 | Vertebral compression fractures (HP:0002953) | 4.04672659 |
| 8 | Abnormality of the common coagulation pathway (HP:0010990) | 3.68538346 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 3.68072058 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.68072058 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.68072058 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.64332969 |
| 13 | Abnormality of the intrinsic pathway (HP:0010989) | 3.60937576 |
| 14 | Complement deficiency (HP:0004431) | 3.56076467 |
| 15 | Premature rupture of membranes (HP:0001788) | 3.48614821 |
| 16 | Ketosis (HP:0001946) | 3.47642230 |
| 17 | Prolonged partial thromboplastin time (HP:0003645) | 3.35082478 |
| 18 | Hyperammonemia (HP:0001987) | 3.31356855 |
| 19 | Hypoglycemic seizures (HP:0002173) | 3.29292001 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 3.24760063 |
| 21 | Hyperglycinuria (HP:0003108) | 3.24726697 |
| 22 | Ketoacidosis (HP:0001993) | 3.21029121 |
| 23 | Cholecystitis (HP:0001082) | 3.20839037 |
| 24 | Abnormal gallbladder physiology (HP:0012438) | 3.20839037 |
| 25 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.14662972 |
| 26 | Hypolipoproteinemia (HP:0010981) | 3.05970553 |
| 27 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.04773663 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.94206230 |
| 29 | Late onset (HP:0003584) | 2.91383152 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.90920188 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 2.90920188 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.90237942 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 2.89260070 |
| 34 | Abnormality of complement system (HP:0005339) | 2.88659152 |
| 35 | Joint hemorrhage (HP:0005261) | 2.87850952 |
| 36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.84644269 |
| 37 | Hyperglycinemia (HP:0002154) | 2.83466637 |
| 38 | Generalized aminoaciduria (HP:0002909) | 2.78819641 |
| 39 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.76904478 |
| 40 | Achilles tendon contracture (HP:0001771) | 2.74774117 |
| 41 | Abnormality of the Achilles tendon (HP:0005109) | 2.70081580 |
| 42 | Myocardial infarction (HP:0001658) | 2.66974076 |
| 43 | Abnormality of macrophages (HP:0004311) | 2.65872845 |
| 44 | Fat malabsorption (HP:0002630) | 2.65367901 |
| 45 | Epidermoid cyst (HP:0200040) | 2.58655269 |
| 46 | Distal lower limb muscle weakness (HP:0009053) | 2.58587700 |
| 47 | Abnormality of purine metabolism (HP:0004352) | 2.58524493 |
| 48 | Purpura (HP:0000979) | 2.57016457 |
| 49 | Rough bone trabeculation (HP:0100670) | 2.55937112 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.54585494 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.54585494 |
| 52 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.49555407 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.47816425 |
| 54 | Hyperglycemia (HP:0003074) | 2.46996717 |
| 55 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.44941987 |
| 56 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.44941987 |
| 57 | Hepatosplenomegaly (HP:0001433) | 2.43200757 |
| 58 | Gout (HP:0001997) | 2.42146457 |
| 59 | Increased cerebral lipofuscin (HP:0011813) | 2.37894530 |
| 60 | Vacuolated lymphocytes (HP:0001922) | 2.37531256 |
| 61 | Hyperbilirubinemia (HP:0002904) | 2.36405125 |
| 62 | Recurrent abscess formation (HP:0002722) | 2.36004196 |
| 63 | Increased serum ferritin (HP:0003281) | 2.35634159 |
| 64 | Loss of speech (HP:0002371) | 2.34207405 |
| 65 | Abnormal cartilage morphology (HP:0002763) | 2.32967406 |
| 66 | Systemic lupus erythematosus (HP:0002725) | 2.32561051 |
| 67 | Symptomatic seizures (HP:0011145) | 2.32184220 |
| 68 | Hepatocellular carcinoma (HP:0001402) | 2.31165143 |
| 69 | Dysostosis multiplex (HP:0000943) | 2.30253573 |
| 70 | Ragged-red muscle fibers (HP:0003200) | 2.29776007 |
| 71 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.29315160 |
| 72 | Dicarboxylic aciduria (HP:0003215) | 2.29315160 |
| 73 | Insulin resistance (HP:0000855) | 2.28664598 |
| 74 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.28568311 |
| 75 | Petechiae (HP:0000967) | 2.27937017 |
| 76 | Skin nodule (HP:0200036) | 2.26481999 |
| 77 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.26400291 |
| 78 | Trismus (HP:0000211) | 2.24694055 |
| 79 | Eczematoid dermatitis (HP:0000976) | 2.24688226 |
| 80 | Hypercholesterolemia (HP:0003124) | 2.24323660 |
| 81 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.23000029 |
| 82 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.23000029 |
| 83 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.23000029 |
| 84 | Spastic diplegia (HP:0001264) | 2.21729307 |
| 85 | Prolonged neonatal jaundice (HP:0006579) | 2.20490729 |
| 86 | Progressive neurologic deterioration (HP:0002344) | 2.20229720 |
| 87 | Multiple enchondromatosis (HP:0005701) | 2.15188348 |
| 88 | Conjugated hyperbilirubinemia (HP:0002908) | 2.15133413 |
| 89 | Amyloidosis (HP:0011034) | 2.13427656 |
| 90 | Abnormal trabecular bone morphology (HP:0100671) | 2.12593066 |
| 91 | Abnormality of methionine metabolism (HP:0010901) | 2.11879631 |
| 92 | J-shaped sella turcica (HP:0002680) | 2.11823921 |
| 93 | Distal upper limb amyotrophy (HP:0007149) | 2.07723497 |
| 94 | Upper limb amyotrophy (HP:0009129) | 2.07723497 |
| 95 | Esophageal varix (HP:0002040) | 2.07682423 |
| 96 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.07312641 |
| 97 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.06266703 |
| 98 | Short nail (HP:0001799) | 2.04804542 |
| 99 | Hypokinesia (HP:0002375) | 2.04377570 |
| 100 | Pancreatitis (HP:0001733) | 2.01648713 |
| 101 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.00435168 |
| 102 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.00435168 |
| 103 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.00000476 |
| 104 | Nonimmune hydrops fetalis (HP:0001790) | 1.98932365 |
| 105 | Recurrent bacterial skin infections (HP:0005406) | 1.98840186 |
| 106 | Hypertensive crisis (HP:0100735) | 1.98309767 |
| 107 | Hemorrhage of the eye (HP:0011885) | 1.98116574 |
| 108 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.97959427 |
| 109 | Obstructive lung disease (HP:0006536) | 1.97290110 |
| 110 | Chronic obstructive pulmonary disease (HP:0006510) | 1.97290110 |
| 111 | Cellulitis (HP:0100658) | 1.95485208 |
| 112 | Protrusio acetabuli (HP:0003179) | 1.92702427 |
| 113 | Abnormality of the umbilical cord (HP:0010881) | 1.92230627 |
| 114 | Hand muscle atrophy (HP:0009130) | 1.89904372 |
| 115 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89798027 |
| 116 | Proximal tubulopathy (HP:0000114) | 1.88272252 |
| 117 | Entropion (HP:0000621) | 1.87661339 |
| 118 | Hydroxyprolinuria (HP:0003080) | 1.87278054 |
| 119 | Abnormality of proline metabolism (HP:0010907) | 1.87278054 |
| 120 | Mitral stenosis (HP:0001718) | 1.87277173 |
| 121 | Axonal loss (HP:0003447) | 1.86923548 |
| 122 | Thrombocytosis (HP:0001894) | 1.86518187 |
| 123 | Back pain (HP:0003418) | 1.86132205 |
| 124 | Polycythemia (HP:0001901) | 1.85433994 |
| 125 | Elbow flexion contracture (HP:0002987) | 1.84837587 |
| 126 | Nausea (HP:0002018) | 1.84496381 |
| 127 | Biconcave vertebral bodies (HP:0004586) | 1.84303759 |
| 128 | Abnormality of serum amino acid levels (HP:0003112) | 1.83684709 |
| 129 | Interstitial pulmonary disease (HP:0006530) | 1.83469937 |
| 130 | Myoglobinuria (HP:0002913) | 1.82994181 |
| 131 | Fasciculations (HP:0002380) | 1.82685459 |
| 132 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81903695 |
| 133 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.80931482 |
| 134 | Osteolytic defects of the hand bones (HP:0009699) | 1.80931482 |
| 135 | Generalized amyotrophy (HP:0003700) | 1.80226957 |
| 136 | Glomerulonephritis (HP:0000099) | 1.80040478 |
| 137 | Steatorrhea (HP:0002570) | 1.79955720 |
| 138 | Hypertriglyceridemia (HP:0002155) | 1.77383194 |
| 139 | Metabolic acidosis (HP:0001942) | 1.75547594 |
| 140 | Delayed CNS myelination (HP:0002188) | 1.75316898 |
| 141 | Flat acetabular roof (HP:0003180) | 1.75287329 |
| 142 | Abnormality of carpal bone ossification (HP:0006257) | 1.74735139 |
| 143 | Menorrhagia (HP:0000132) | 1.74359550 |
| 144 | Progressive muscle weakness (HP:0003323) | 1.74259834 |
| 145 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.74156895 |
| 146 | Bone pain (HP:0002653) | 1.72167219 |
| 147 | Type I transferrin isoform profile (HP:0003642) | 1.71345112 |
| 148 | Abnormality of iron homeostasis (HP:0011031) | 1.71110229 |
| 149 | Cervical subluxation (HP:0003308) | 1.70744255 |
| 150 | Upper motor neuron abnormality (HP:0002127) | 1.70069375 |
| 151 | Cerebral aneurysm (HP:0004944) | 1.69447212 |
| 152 | Protuberant abdomen (HP:0001538) | 1.69276922 |
| 153 | Blue sclerae (HP:0000592) | 1.69016653 |
| 154 | Microvesicular hepatic steatosis (HP:0001414) | 1.68599361 |
| 155 | Beaking of vertebral bodies (HP:0004568) | 1.68271852 |
| 156 | Gingival bleeding (HP:0000225) | 1.67941929 |
| 157 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.67896661 |
| 158 | Reduced antithrombin III activity (HP:0001976) | 1.66812233 |
| 159 | Abnormal platelet function (HP:0011869) | 1.66360351 |
| 160 | Impaired platelet aggregation (HP:0003540) | 1.66360351 |
| 161 | Elevated alkaline phosphatase (HP:0003155) | 1.66278084 |
| 162 | Polygenic inheritance (HP:0010982) | 1.65689652 |
| 163 | Irritability (HP:0000737) | 1.65480398 |
| 164 | Joint stiffness (HP:0001387) | 1.63697631 |
| 165 | Cholelithiasis (HP:0001081) | 1.62574606 |
| 166 | Nuclear cataract (HP:0100018) | 1.61847308 |
| 167 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.59829998 |
| 168 | Microretrognathia (HP:0000308) | 1.59153369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.63640498 |
| 2 | TRIB3 | 4.52820648 |
| 3 | BCKDK | 3.50647702 |
| 4 | PKN2 | 3.20221325 |
| 5 | SMG1 | 2.85522219 |
| 6 | VRK2 | 2.57389934 |
| 7 | SIK1 | 2.53189593 |
| 8 | TAOK3 | 2.44196412 |
| 9 | FLT3 | 2.18470007 |
| 10 | FGFR4 | 2.15054841 |
| 11 | MAP3K10 | 2.08414337 |
| 12 | EEF2K | 2.01591059 |
| 13 | KDR | 2.00678871 |
| 14 | SCYL2 | 1.92007289 |
| 15 | ARAF | 1.90892436 |
| 16 | PTK6 | 1.87412386 |
| 17 | TAOK2 | 1.86995794 |
| 18 | PRPF4B | 1.81835102 |
| 19 | PASK | 1.69401071 |
| 20 | IRAK3 | 1.67689499 |
| 21 | LRRK2 | 1.62498658 |
| 22 | MAP4K1 | 1.59054759 |
| 23 | INSRR | 1.54452083 |
| 24 | TYK2 | 1.47646693 |
| 25 | NME2 | 1.45762028 |
| 26 | LIMK1 | 1.41935282 |
| 27 | MAP2K3 | 1.38674734 |
| 28 | EPHA2 | 1.37707427 |
| 29 | PIK3CG | 1.33590956 |
| 30 | TESK2 | 1.29771698 |
| 31 | ICK | 1.29111177 |
| 32 | ZAP70 | 1.27465980 |
| 33 | TBK1 | 1.19980569 |
| 34 | RPS6KA4 | 1.18882451 |
| 35 | MAP3K3 | 1.15567953 |
| 36 | PAK4 | 1.12807461 |
| 37 | JAK3 | 1.10370897 |
| 38 | NEK9 | 1.09707017 |
| 39 | FRK | 1.09426033 |
| 40 | TTN | 1.06097261 |
| 41 | TGFBR2 | 1.04518608 |
| 42 | MST1R | 1.03831722 |
| 43 | RIPK1 | 1.03577044 |
| 44 | STK10 | 1.03166124 |
| 45 | MAPKAPK3 | 1.00877280 |
| 46 | PBK | 0.99939704 |
| 47 | PDGFRA | 0.99444276 |
| 48 | LMTK2 | 0.98619272 |
| 49 | JAK1 | 0.95416868 |
| 50 | TESK1 | 0.92015917 |
| 51 | EPHB1 | 0.91717270 |
| 52 | STK16 | 0.90930618 |
| 53 | JAK2 | 0.89690797 |
| 54 | TIE1 | 0.89281444 |
| 55 | MAPK11 | 0.88853293 |
| 56 | BTK | 0.88569109 |
| 57 | CDK6 | 0.88353803 |
| 58 | MAP3K11 | 0.87181917 |
| 59 | EIF2AK3 | 0.86580880 |
| 60 | MAP3K8 | 0.84425481 |
| 61 | NEK2 | 0.83246202 |
| 62 | BLK | 0.82854764 |
| 63 | CDK4 | 0.81837776 |
| 64 | PDK2 | 0.81758348 |
| 65 | RPS6KB2 | 0.81678161 |
| 66 | CAMK1D | 0.81572740 |
| 67 | AURKA | 0.81297085 |
| 68 | BRSK2 | 0.79817930 |
| 69 | CDK7 | 0.79167296 |
| 70 | EIF2AK1 | 0.77023822 |
| 71 | MAP2K2 | 0.76990022 |
| 72 | TAOK1 | 0.76776814 |
| 73 | GRK6 | 0.76331401 |
| 74 | LATS1 | 0.75571718 |
| 75 | BRAF | 0.74415058 |
| 76 | MTOR | 0.71941849 |
| 77 | PTK2 | 0.71090389 |
| 78 | DAPK1 | 0.70598621 |
| 79 | TGFBR1 | 0.69999291 |
| 80 | EPHA3 | 0.68107692 |
| 81 | CDK12 | 0.67806516 |
| 82 | DYRK1B | 0.66455032 |
| 83 | MAP3K14 | 0.66047257 |
| 84 | NEK1 | 0.64305300 |
| 85 | FGFR3 | 0.63786182 |
| 86 | CSK | 0.60844127 |
| 87 | MET | 0.60478959 |
| 88 | CSF1R | 0.59980933 |
| 89 | SRPK1 | 0.59650453 |
| 90 | BUB1 | 0.59633399 |
| 91 | ABL2 | 0.57677002 |
| 92 | WEE1 | 0.57387994 |
| 93 | PAK1 | 0.57341173 |
| 94 | HIPK2 | 0.56464954 |
| 95 | ITK | 0.55656988 |
| 96 | MAPKAPK2 | 0.55582813 |
| 97 | IKBKB | 0.55252814 |
| 98 | KIT | 0.54415973 |
| 99 | TLK1 | 0.54244509 |
| 100 | TEC | 0.54225437 |
| 101 | BMX | 0.53376103 |
| 102 | MOS | 0.53140782 |
| 103 | MAP3K1 | 0.52262194 |
| 104 | PDPK1 | 0.50775158 |
| 105 | PAK2 | 0.50404729 |
| 106 | PIM1 | 0.49631399 |
| 107 | CLK1 | 0.49516028 |
| 108 | MAP3K12 | 0.48498393 |
| 109 | PIM2 | 0.48395221 |
| 110 | DAPK3 | 0.45576179 |
| 111 | CDK8 | 0.45033011 |
| 112 | STK3 | 0.44405807 |
| 113 | ILK | 0.40970515 |
| 114 | PRKCI | 0.40041514 |
| 115 | BRSK1 | 0.39754638 |
| 116 | IKBKE | 0.39594285 |
| 117 | IRAK4 | 0.38460483 |
| 118 | PRKD2 | 0.36856613 |
| 119 | SIK3 | 0.36734569 |
| 120 | MATK | 0.36576821 |
| 121 | MYLK | 0.35169461 |
| 122 | AURKB | 0.34967686 |
| 123 | ERBB4 | 0.34823211 |
| 124 | IRAK2 | 0.34102665 |
| 125 | CHUK | 0.33024999 |
| 126 | STK4 | 0.32356200 |
| 127 | PRKAA2 | 0.32229667 |
| 128 | ACVR1B | 0.32049279 |
| 129 | FES | 0.31736233 |
| 130 | DYRK3 | 0.31428063 |
| 131 | PRKG2 | 0.30498949 |
| 132 | TTK | 0.30327763 |
| 133 | CDC42BPA | 0.29886293 |
| 134 | GSK3A | 0.29224063 |
| 135 | MAPK15 | 0.28960669 |
| 136 | AKT2 | 0.28397692 |
| 137 | ALK | 0.25414325 |
| 138 | MAP3K7 | 0.25373128 |
| 139 | NLK | 0.25194458 |
| 140 | PRKAA1 | 0.24995932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.10404752 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.93051730 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.77341555 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.59464052 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 2.57639762 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49079514 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.40700230 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36453840 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.34798909 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.34731175 |
| 11 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.25177271 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.14407977 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.07704273 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.05268266 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.04357457 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.84243638 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.83484843 |
| 18 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.82739666 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74554084 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.74282519 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.67840167 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.66436249 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.65838411 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.65753204 |
| 25 | Base excision repair_Homo sapiens_hsa03410 | 1.62564785 |
| 26 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.57333095 |
| 27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.56438494 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.54226967 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51926994 |
| 30 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.50151890 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.48072852 |
| 32 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.47219618 |
| 33 | Carbon metabolism_Homo sapiens_hsa01200 | 1.46537232 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.38528993 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35820551 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.35030440 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.35015538 |
| 38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.34893562 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.31813370 |
| 40 | Sulfur relay system_Homo sapiens_hsa04122 | 1.30084909 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.27122067 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.24941634 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23058754 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.18143190 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.17578552 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.17510967 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.16707184 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.15362309 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12517363 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 1.11494775 |
| 51 | Protein export_Homo sapiens_hsa03060 | 1.08343867 |
| 52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.05747781 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.05258133 |
| 54 | Bile secretion_Homo sapiens_hsa04976 | 0.99335506 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.99179840 |
| 56 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97213365 |
| 57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96523098 |
| 58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96309669 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.94752535 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.94543364 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.94101155 |
| 62 | Galactose metabolism_Homo sapiens_hsa00052 | 0.93415907 |
| 63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.92909854 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.92520416 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91715548 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.87749813 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.87015676 |
| 68 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.86760950 |
| 69 | Spliceosome_Homo sapiens_hsa03040 | 0.84464537 |
| 70 | Apoptosis_Homo sapiens_hsa04210 | 0.84289221 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84287407 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.84195284 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79344626 |
| 74 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.78790142 |
| 75 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78599926 |
| 76 | Mismatch repair_Homo sapiens_hsa03430 | 0.77344791 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.76950951 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.76923785 |
| 79 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76245679 |
| 80 | Allograft rejection_Homo sapiens_hsa05330 | 0.76219973 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75825845 |
| 82 | Leishmaniasis_Homo sapiens_hsa05140 | 0.74666983 |
| 83 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71918486 |
| 84 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.70427128 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.69550236 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68824542 |
| 87 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68655158 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67905520 |
| 89 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67742333 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.64993389 |
| 91 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63961427 |
| 92 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.61844151 |
| 93 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59994851 |
| 94 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.58454161 |
| 95 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.58360778 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.57741514 |
| 97 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.57626143 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56246802 |
| 99 | Influenza A_Homo sapiens_hsa05164 | 0.56121467 |
| 100 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.55566058 |
| 101 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.53980113 |
| 102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51605446 |
| 103 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.51321758 |
| 104 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.51181125 |
| 105 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.50969071 |
| 106 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50472954 |
| 107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49858843 |
| 108 | RNA polymerase_Homo sapiens_hsa03020 | 0.49171673 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47535149 |
| 110 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45671945 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45137496 |
| 112 | Legionellosis_Homo sapiens_hsa05134 | 0.44924298 |
| 113 | DNA replication_Homo sapiens_hsa03030 | 0.43442580 |
| 114 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.42917272 |
| 115 | Tuberculosis_Homo sapiens_hsa05152 | 0.41899528 |
| 116 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41070262 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41056638 |
| 118 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.36653699 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35982350 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.32696634 |
| 121 | Bladder cancer_Homo sapiens_hsa05219 | 0.32551206 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31682850 |
| 123 | Prion diseases_Homo sapiens_hsa05020 | 0.27811105 |
| 124 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.24605694 |
| 125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.23795793 |
| 126 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.23520872 |
| 127 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22394798 |
| 128 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.21060490 |
| 129 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.19228145 |
| 130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.19023489 |
| 131 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.18043659 |
| 132 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.17750140 |
| 133 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.17708345 |
| 134 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.15841549 |
| 135 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.15468325 |
| 136 | Ribosome_Homo sapiens_hsa03010 | 0.14276571 |
| 137 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.13992361 |
| 138 | Thyroid cancer_Homo sapiens_hsa05216 | 0.12274397 |
| 139 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.10109406 |

